Discovery of 1 -(5 -br omo pyr azi n-2 -yl )-1 -[3 -(t rif uo rom eth yl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies (original) (raw)

Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies

Saba Beigh

Scientific Reports, 2023

View PDFchevron_right

Design, Synthesis and Anticancer Activity of a New Series of N-aryl-N′-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives

Ahmad Shumayal

Molecules, 2021

View PDFchevron_right

Antiproliferative Activity, Cell Cycle, and Apoptosis Studies of a Series of 6‐Substituted 9H‐Purin‐9‐yl‐pyridinium Derivatives on a Human Cervical Carcinoma Cell Line

Rosario Sánchez-Martín

ChemMedChem, 2013

View PDFchevron_right

Antiproliferative Activity, Cell Cycle, and Apoptosis Studies of a Series of 6-Substituted 9H-Purin-9-yl-pyridinium Derivatives on a Human Cervical Carcinoma Cell Line

Ana Conejo-garcía

ChemMedChem, 2013

View PDFchevron_right

Synthesis and anticancer activity of ( RS)-9-(2,3-dihydro-1,4-benzoxaheteroin-2-ylmethyl)-9 H-purine

Alberto Ramirez

Solar Energ, 2011

View PDFchevron_right

Molecular – Docking Studies of Potent Anticancer Agent

Sunil Ganatra

Journal of Computer Science & Systems Biology, 2012

View PDFchevron_right

Design, synthesis, anticancer evaluation and molecular docking of new V600EBRAF inhibitors derived from pyridopyrazinone

Prof. Mandava venkata Basaveswara Rao

European Journal of Chemistry, 2016

View PDFchevron_right

Antitumor agents 287. Substituted 4-amino-2H-pyran-2-one (APO) analogs reveal a new scaffold from neo-tanshinlactone with in vitro anticancer activity

Kyoko Nakagawa-goto

Bioorganic & Medicinal Chemistry Letters, 2011

View PDFchevron_right

Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents

Iqbal Azad

Journal of Molecular Graphics & Modelling, 2018

View PDFchevron_right

Design, Molecular Modeling and Synthesis of Some New Purine-diones and Pyridopyrimidine-diones with Anticancer Activity

Alaa Hayallah

JOURNAL OF ADVANCES IN CHEMISTRY

View PDFchevron_right

Synthesis and Molecular Docking Study of 4-(3-(2-Chlorophenyl)-5-(2-Methoxyphenyl)-4,5-Dihydro-1H-Pyrazol-1-yl) Benzenesulfonamide as Antibreast Cancer Agent

Adel Zamri

ALCHEMY Jurnal Penelitian Kimia, 2021

View PDFchevron_right

Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights

Mahmoud Elaasser

Journal of Enzyme Inhibition and Medicinal Chemistry

View PDFchevron_right

Antitumor Agents. 1. Synthesis, Biological Evaluation, and Molecular Modeling of 5 H-Pyrido [3, 2-a] phenoxazin-5-one, a Compound with Potent Antiproliferative …

Antonio Lavecchia

Journal of medicinal …, 2002

View PDFchevron_right

Structure-Based Development of Anticancer Drugs

Mario Bianchet

Structure, 2001

View PDFchevron_right

Synthesis and anticancer activity of (RS)-9-(2,3-dihydro-1,4-benzoxaheteroin-2-ylmethyl)-9H-purines

antonia aranega

European Journal of Medicinal Chemistry, 2011

View PDFchevron_right

Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis Authors

Manar Ahmed Fouad, Mohammed Salah Ayoup

European Journal of Medicinal Chemistry, 2020

View PDFchevron_right

Anti-Cancer Agents in Medicinal Chemistry

Chinweike Eze

Bentham sciences, 2022

View PDFchevron_right

Design, Synthesis and Anticancer Activity Against the MCF-7 Cell Line of Benzo-Fused 1,4-Dihetero Seven- and Six-Membered Tethered Pyrimidines and Purines

Ana Conejo-garcía

Current Medicinal Chemistry, 2008

View PDFchevron_right

Characterization of a membrane-active anti-tumor agent, UA8967

Komath Damodaran

Investigational New Drugs, 2012

View PDFchevron_right

Design, synthesis and structure–activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents

Korany Ali

European Journal of Medicinal Chemistry, 2010

View PDFchevron_right

Synthesis, in vitro, and in silico studies of novel poly‐heterocyclic compounds bearing pyridine and furan moieties as potential anticancer agents

Hasan Kucukbay

Journal of Molecular Structure, 2023

View PDFchevron_right

Novel series of 1, 5 Benzothiazepine skeleton based compounds as anti-cancer agents -In silico and MTT assay based study

Chennu MMPrasada Rao

View PDFchevron_right

Antitumor Agents. 1. Synthesis, Biological Evaluation, and Molecular Modeling of 5H-Pyrido[3,2-a]phenoxazin-5-one, a Compound with Potent Antiproliferative Activity

Adele Bolognese

Journal of Medicinal Chemistry, 2002

View PDFchevron_right

Discovery of novel anticancer candidates based on a combination strategy of synthesis, characterization, biological activity evaluation, consensus docking and molecular modeling

hend hekal

Journal of the Iranian Chemical Society

View PDFchevron_right

Unveiling the antitumor potential of novel N-(substituted-phenyl)-8-methoxycoumarin-3carboxamides as dual inhibitors of VEGFR2 kinase and cytochrome P450 for targeted treatment of hepatocellular carcinoma

Mariusz Jaremko

Frontiers in Chemistry, 2023

View PDFchevron_right

Synthesis and In Vitro Antiproliferative Activity of New 1-Phenyl-3-(4-(pyridin-3-yl)phenyl)urea Scaffold-Based Compounds

Mohamed E . Shaker

View PDFchevron_right

Design synthesis and evaluation of anticancer activity of heterocyclic compounds

ojaswi ghadge

Shodhganga, 2019

View PDFchevron_right

In Vitro, Molecular Docking, and In Silico Binding Mode Analysis of Organic Compounds for Antimicrobial and Anticancer Activity against Jurkat, HCT116, and A549 Cell Lines

Sanay Naha

ChemistrySelect, 2020

View PDFchevron_right